Search Results - "Puig, Luis"

Tyk2 Targeting in Immune-Mediated Inflammatory Diseases by Rusiñol, Lluís, Puig, Luis

“…The Janus kinase (Jak)/signal transducer and activating protein (STAT) pathways mediate the intracellular signaling of cytokines in a wide spectrum of cellular…”
Get full text

Long-term efficacy and safety of brodalumab in the treatment of psoriasis: 120-week results from the randomized, double-blind, placebo- and active comparator–controlled phase 3 AMAGINE-2 trial by Puig, Luis, Lebwohl, Mark, Bachelez, Hervé, Sobell, Jeffrey, Jacobson, Abby A.

“…Randomized controlled trials have shown the efficacy and safety of brodalumab in patients with moderate to severe plaque psoriasis. To evaluate the efficacy…”
Get full text

Risk Factors for Degree and Type of Sequelae After Involution of Untreated Hemangiomas of Infancy by Baselga, Eulalia, Roe, Esther, Coulie, Julien, Muñoz, Fania Z, Boon, Laurence M, McCuaig, Catherine, Hernandez-Martín, Angela, Gich, Ignasi, Puig, Luis

“…Infantile hemangiomas involute to some extent, but they often leave sequelae that may cause disfigurement. Factors determining the risk of permanent sequelae…”
Get more information

Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions by Davidovici, Batya B., Sattar, Naveed, Jörg, Prinz C., Puig, Luis, Emery, Paul, Barker, Jonathan N., van de Kerkhof, Peter, Ståhle, Mona, Nestle, Frank O., Girolomoni, Giampiero, Krueger, James G.

“…Psoriasis is now classified as an immune-mediated inflammatory disease (IMID) of the skin. It is being recognized that patients with various IMIDs, including…”
Get full text

Impact of ixekizumab on psoriasis itch severity and other psoriasis symptoms: Results from 3 phase III psoriasis clinical trials by Kimball, Alexandra B., MD, MPH, Luger, Thomas, MD, PhD, Gottlieb, Alice, MD, PhD, Puig, Luis, MD, PhD, Kaufmann, Roland, MD, Nikaï, Enkeleida, MS Psy, Zhu, Baojin, PhD, Edson-Heredia, Emily, MPH, Carlier, Hilde, MD, Lin, Chen-Yen, PhD, Goldblum, Orin, MD, Yosipovitch, Gil, MD

“…Background Itch is a prevalent symptom of psoriasis that impacts quality of life. Objective We sought to describe improvements in itch severity, skin pain, and…”
Get full text

Generalized Pustular Psoriasis: A Review on Clinical Characteristics, Diagnosis, and Treatment by Rivera-Díaz, Raquel, Daudén, Esteban, Carrascosa, José Manuel, Cueva, Pablo de la, Puig, Luis

“…Generalized pustular psoriasis (GPP) is a rare, chronic, and severe inflammatory skin disorder characterized by sudden eruption of sterile pustules, often…”
Get full text

Nomenclature and clinical phenotypes of atopic dermatitis by Girolomoni, Giampiero, de Bruin-Weller, Marjolein, Aoki, Valeria, Kabashima, Kenji, Deleuran, Mette, Puig, Luis, Bansal, Ashish, Rossi, Ana B.

“…Atopic dermatitis is a heterogeneous disease and resists classification. In this review, we discuss atopic dermatitis nomenclature and identify morphologic…”
Get full text

The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases by Navarro-Compán, Victoria, Puig, Luis, Vidal, Silvia, Ramírez, Julio, Llamas-Velasco, Mar, Fernández-Carballido, Cristina, Almodóvar, Raquel, Pinto, José Antonio, Galíndez-Aguirregoikoa, Eva, Zarco, Pedro, Joven, Beatriz, Gratacós, Jordi, Juanola, Xavier, Blanco, Ricardo, Arias-Santiago, Salvador, Sanz Sanz, Jesús, Queiro, Rubén, Cañete, Juan D

“…Interleukin-17 family (IL-17s) comprises six structurally related members (IL-17A to IL-17F); sequence homology is highest between IL-17A and IL-17F,…”
Get full text

Predictors of Local Invasion in Infiltrative Basal Cell Carcinoma: Tumour Budding Outperforms the WHO Subtyping by Fernandez-Figueras, Maria Teresa, Perez-Muñoz, Noelia, Puig, Luis, Posada-Caez, Rodolfo, Ballester Victoria, Rosa, Henriquez, Martha, Musulen, Eva

“…Tumour budding (TB) correlates with increased local invasion in various neoplasms. Certain basal cell carcinomas (BCCs) exhibit local aggressiveness. Detecting…”
Get full text

Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24–28 and 48–52 weeks by Egeberg, Alexander, Kristensen, Lars Erik, Puig, Luis, Rich, Phoebe, Smith, Saxon D., Garrelts, Alyssa, See, Kyoungah, Holzkaemper, Thorsten, Fotiou, Konstantinos, Schuster, Christopher

“…BACKGROUNDAvailable network meta-analyses (NMAs) comparing the efficacy of biologics in nail psoriasis (NP) have not included recently approved biologics such…”
Get full text

Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis by Armstrong, April W., Soliman, Ahmed M., Betts, Keith A., Wang, Yan, Gao, Yawen, Puig, Luis, Augustin, Matthias

“…Introduction The clinical benefits of biologic and oral treatments for moderate-to-severe plaque psoriasis are well-established, but efficacy outcomes can vary…”
Get full text

PsoBarrier EU study: a Multicentre, Cross-sectional Survey Investigating the Quality of Psoriasis Care in Four European Countries by Langenbruch, Anna, Mohr, Nicole, Andrees, Valerie, Kessens, Ihno, Reich, Adam, Czarnecka-Operacz, Magdalena, Puig, Luis, Dauden, Esteban, Iversen, Lars, Augustin, Matthias

“…Enhanced treatment options for psoriasis and growing use of guidelines increased the potential to better quality of psoriasis care in Europe. The aim of the…”
Get full text

Real-World Discontinuation and Switching Patterns for Interleukin-Inhibitor Treatments in Patients with Moderate-to-Severe Psoriasis in Japan by Tada, Yayoi, Soliman, Ahmed M., Ishii, Kanako, Sakuma, Ryuta, Puig, Luis, Davis, Matthew, Nunag, Dominic, Pinter, Andreas, Imafuku, Shinichi

“…Introduction Patients with moderate-to-severe psoriasis (PsO) treated with interleukin (IL)-inhibitors may require treatment modification to achieve disease…”
Get full text

Calibration of omnidirectional cameras in practice: A comparison of methods by Puig, Luis, Bermúdez, J., Sturm, Peter, Guerrero, J.J.

“…► Survey of four calibration methods for central catadioptric systems. ► Three different central catadioptric systems and one non-central fish-eye lens were…”
Get full text

Drug survival of conventional systemic and biologic therapies for moderate-to-severe psoriasis in clinical practice in Spain: prospective results from the SAHARA study by Puig, Luis, Carrascosa, José-Manuel, Daudén, Esteban, Sulleiro, Sara, Guisado, Cristina

“…Background: A better understanding of determinants for drug survival of antipsoriatic agents may guide dermatologists in the right therapeutic choice…”
Get full text

Increasing Access to Effective Systemic Treatments in Patients with Moderate-to-Severe Psoriasis: Narrative Review by Girolomoni, Giampiero, Savage, Laura, Gisondi, Paolo, Svensson, Åke, Mahé, Emmanuel, Augustin, Matthias, Puig, Luis

“…Psoriasis is a chronic, immune-mediated inflammatory disease with a worldwide prevalence ranging between 0.51 and 11.43%. It results in a large clinical and…”
Get full text

Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure by Armstrong, April, Paul, Carle, Puig, Luis, Boehncke, Wolf Henning, Freeman, Michael, Torii, Hideshi, Papp, Kim, Griffiths, Christopher E. M., Blauvelt, Andrew, Reich, Kristian, Gooderham, Melinda, Terui, Tadashi, Renda, Lisa, Agada, Noah, Xu, Wen, Gallo, Gaia, Lebwohl, Mark G.

“…Introduction Long-term safety data are critical for evaluating therapies for psoriasis. Ixekizumab has demonstrated efficacy and is well tolerated for the…”
Get full text

Real-World Long-Term Effectiveness of Risankizumab Among Patients with Moderate-to-Severe Psoriasis: Analysis from an International Medical Chart Review (RAPID) Study by Pinter, Andreas, Soliman, Ahmed M., Pivneva, Irina, Ghanbariamin, Roksana, Yang, Min, Truong, Bang, Puig, Luis, Lebwohl, Mark

“…Introduction Real-world data on the efficacy of risankizumab (RZB) in clinical moderate-to-severe plaque psoriasis (PsO) are limited. The RAPID study assessed…”
Get full text

IL-1 Family Cytokines in Inflammatory Dermatoses: Pathogenetic Role and Potential Therapeutic Implications by Iznardo, Helena, Puig, Luís

“…The interleukin-1 (IL-1) family is involved in the correct functioning and regulation of the innate immune system, linking innate and adaptative immune…”
Get full text

Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants by Luger, Thomas, Boguniewicz, Mark, Carr, Warner, Cork, Michael, Deleuran, Mette, Eichenfield, Lawrence, Eigenmann, Philippe, Fölster-Holst, Regina, Gelmetti, Carlo, Gollnick, Harald, Hamelmann, Eckard, Hebert, Adelaide A., Muraro, Antonella, Oranje, Arnold P., Paller, Amy S., Paul, Carle, Puig, Luis, Ring, Johannes, Siegfried, Elaine, Spergel, Jonathan M., Stingl, Georg, Taieb, Alain, Torrelo, Antonio, Werfel, Thomas, Wahn, Ulrich

“…Atopic dermatitis (AD) is a distressing dermatological disease, which is highly prevalent during infancy, can persist into later life and requires long‐term…”
Get full text